Yeah its just a rebrand but they are getting close to US direct to consumer launch.
But the market awaits bigger fish. AZ sales estimates for FY19. And a hook up with a ridgy didge payer/insurer. Oh yeah and the release of AZs new product. That would be nice. If I wasnt a cynic, maybe they are saving some of these for a cap raising in the not too distant future...
On another matter, I find it curious that at the last conference call earlier this month, they were still sticking to the $5.7 - $7M revenue guidance for the FY ending 30 June. Given first half revenue was $2.6 million (I believe), where is the $3 to 4 million coming from in the second half? Another AZ R&D payment?
Yeah its just a rebrand but they are getting close to US direct...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.861M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 288622 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 293516 | 1 |
View Market Depth
| Last trade - 16.12pm 11/09/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable